Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19696440 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy
Conditions: Allergic Rhinitis;   Asthma
Interventions: Drug: (agent for immunotherapy) Staloral;   Drug: Placebo

Indicates status has not been verified in more than two years